3,703 Shares in GE HealthCare Technologies Inc. $GEHC Purchased by Paloma Partners Management Co

Paloma Partners Management Co bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 1st quarter, Holdings Channel reports. The fund bought 3,703 shares of the company’s stock, valued at approximately $299,000.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. N.E.W. Advisory Services LLC acquired a new stake in GE HealthCare Technologies in the 1st quarter worth about $25,000. Bogart Wealth LLC raised its stake in GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after purchasing an additional 247 shares in the last quarter. Stonebridge Financial Group LLC raised its stake in GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock worth $29,000 after purchasing an additional 222 shares in the last quarter. Accredited Wealth Management LLC acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $30,000. Finally, Ameriflex Group Inc. acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $31,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC stock opened at $73.73 on Monday. The company has a 50 day simple moving average of $74.23 and a 200 day simple moving average of $74.55. The stock has a market cap of $33.66 billion, a price-to-earnings ratio of 15.11, a P/E/G ratio of 2.82 and a beta of 1.13. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies’s payout ratio is presently 2.87%.

Analyst Ratings Changes

Several analysts have weighed in on GEHC shares. BTIG Research reiterated a “buy” rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Morgan Stanley dropped their price objective on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating for the company in a research note on Thursday, July 31st. Wall Street Zen upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 31st. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and cut their price target for the stock from $74.00 to $73.00 in a report on Monday, May 5th. Finally, Zacks Research raised shares of GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $88.55.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.